Actively Recruiting
Evaluating the Effectiveness of Fish Oil and Algae Oil Supplements on Omega-3 Levels in Healthy Adults with Low Fatty Fish Intake
Led by Nordic Naturals · Updated on 2026-10-28
600
Participants Needed
1
Research Sites
5 weeks
Total Duration
AI-Summary
What This Trial Is About
Heart disease is the leading cause of death worldwide, and the Omega-3 Index O3I measures the levels of omega-3 fats EPA and DHA in red blood cells. Research shows that people with an O3I above 8% have a lower risk of dying from coronary heart disease compared to those with an O3I below 4%. This study aims to evaluate how different marine oil products affect omega-3 status in healthy adults who consume little fatty fish. Participants will receive either fish oil or algae oil products in various forms such as softgels, liquids, and gummies. The trial includes placebo groups and several experimental groups using different marine oil supplements. Participants are asked to keep their usual diet, activity, medications, supplements, and lifestyle habits consistent during the study. Throughout the study, participants will complete questionnaires, diaries, and assessments to monitor their omega-3 status. Blood tests will measure the Omega-3 Index after three months to evaluate changes. The study also tracks adherence to study products and lifestyle stability to ensure reliable results over the trial period.
CONDITIONS
Brief Title
A Randomized, Double-blind, Placebo Controlled, Parallel Virtual Clinical Trial to Investigate the Efficacy of Marine Oil Products on Omega-3 Status in Healthy Adults
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here